# Research memo

## Background
Tesla's stock traded at $330.56 on August 15, 2025, after a volatile period that saw prices range from ~$294 to ~$349 over the prior two months. The Q2 2025 10-Q (filed July 24) revealed year-over-year revenue declines—total revenue fell to $22.5B from $25.5B and automotive sales dropped to $15.8B from $18.5B—while net income fell to $1.19B from $1.42B. On August 4, Tesla's board announced a new interim CEO compensation award of 96 million restricted shares to Elon Musk, reigniting governance and dilution concerns amid ongoing Delaware litigation over the 2018 performance award.

## Bull case
Tesla's energy generation and storage segment showed strength, with six-month sales rising to $5.5B from $4.6B year-over-year, and the company maintained a robust cash position of $15.6B plus $21.2B in short-term investments. The new CEO compensation award, while controversial, is designed to retain Musk through a critical AI and robotics inflection point, which could unlock significant long-term value. FSD deferred revenue grew to $3.75B from $3.60B, suggesting continued monetization potential from software. The stock has already recovered from its early-July lows near $294 to the $330 range, indicating market absorption of negative Q2 results.

## Bear case
Q2 2025 financials show significant deterioration: automotive sales fell 15% YoY, total revenue declined 12%, operating income dropped 42% to $923M, and net income fell 16% to $1.19B. R&D expenses surged 48% to $1.59B while gross profit declined 15% to $3.88B, compressing margins. The August 4 announcement of 96 million new restricted shares for Musk introduces substantial dilution risk—representing roughly 3% of the 3.225B shares outstanding—and the Delaware litigation over the 2018 award remains unresolved with no clear timeline. Inventory grew to $14.6B from $12.0B, signaling potential demand softness in the core automotive business.

## Conclusion
Tesla faces conflicting forces: deteriorating automotive fundamentals and significant dilution risk from the new CEO award weigh on near-term prospects, while the energy segment growth and large cash reserves provide a floor. The unresolved Delaware litigation and the sheer scale of the new share grant create an overhang that is likely to cap upside over the next 40 trading days. I expect TSLA to drift modestly lower as the market digests the dilution and weak auto trajectory, with elevated volatility given the binary nature of pending legal outcomes.

## Claims
- `c1` [direction, 40d, conf 0.45] TSLA closes at least 5% below the as-of price ($330.56) on the 40th trading day after August 15, 2025 -> **miss** (horizon-end return +31.87% vs down 5.0%)
- `c2` [magnitude, 40d, conf 0.35] TSLA's 40-trading-day return lands between -5% and -15% -> **miss** (horizon-end return +31.87% vs [-15.0, -5.0])
- `c3` [volatility, 40d, conf 0.55] TSLA's realized daily log-return volatility over the 40 trading days after August 15, 2025 exceeds the 75th percentile of same-length rolling windows from the prior ~252 trading days -> **miss** (realized vol 0.03107 vs p75 0.05062 (above))
